Advertisement

February 3, 2020

Indication Approved for Merit Medical’s EmboCube and Torpedo for Embolization to Occlude Blood Flow

February 3, 2020—Merit Medical Systems, Inc. announced that both its EmboCube and Torpedo devices are now FDA indicated for the embolization of blood vessels to occlude blood flow, which helps control bleeding and hemorrhaging in the peripheral vasculature.

According to the company, the new indication for EmboCube and Torpedo conveys the devices’ safety and efficacy for blood flow occlusion in adult patients.

EmboCube is delivered precut and preloaded into a syringe for efficiency and ease of use. Torpedo is a uniformly preshaped gelatin foam loaded into a cartridge with an optional blunt stylet, eliminating the need for manual foam shaping, and provides fast and easy attachment to the catheter for delivery. The devices are made of porcine gelatin and have no ferrous composition, making it safe for use in patients undergoing MRI, stated Merit Medical.

Advertisement


February 4, 2020

Enrollment Completed in Pivotal Trial of Laminate’s VasQ Device

February 3, 2020

MedAlliance’s Selution SLR Receives CE Mark Approval